CRP and acute respiratory distress syndrome: Although further research is still needed on the efficacy differences of NE inhibitors in different ARDS subtypes at present, the existing evidence indicates that NE inhibitors (such as sivelestat sodium) can exert potential pulmonary protective effects by down-regulating the levels of inflammatory markers such as IL-6 and CRP (19).